Amanta Healthcare Ltd. IPO

About Amanta Healthcare IPO
Amanta Healthcare IPO is a book build issue worth ₹126.00 crore. The entire issue consists of a fresh issue of 1.00 crore equity shares amounting t ...

The allotment of shares is expected to be finalised on September 4, 2025, and the shares are likely to be listed on BSE and NSE with a tentative listing date set for September 9, 2025. The price band for Amanta Healthcare IPO is fixed between ₹120.00 and ₹126.00 per share.

The minimum lot size is 119 shares, requiring a retail investor to invest at least ₹14,994 at the upper price band. For non-institutional investors, the lot size investment differs: sNII is required to apply for 14 lots (1,666 shares) amounting to ₹2,09,916, while bNII needs to apply for 67 lots (7,973 shares) worth ₹10,04,598.

Beeline Capital Advisors Private Limited is acting as the book-running lead manager for this issue, while MUFG Intime India Private Limited has been appointed as the registrar.

Read more
Min Investment
₹14,994 / 119 shares
Price Range
₹120 - ₹126
Premium GMP%
28 (22%)
Listing Gain
%
Total Issue Size
₹126 Cr
Fresh Issue
₹126 Cr
Offer For Sale
- Cr
Listing At
NSE & BSE
Retail Quota
35%
Qib + Nii Quota
50% + 15%
Face Value
10
Subscription
-
Check Live Subscription

IPO Timeline

  • 01 Sep 2025
    Bidding Starts
  • 03 Sep 2025
    Bidding Ends
  • 04 Sep 2025
    Allotment Finalization
  • 08 Sep 2025
    Refund Date
  • 08 Sep 2025
    Demat Date
  • 09 Sep 2025
    Listing Date
Check Allotment Status

Amanta Healthcare Ltd. IPO Financial Result in crore

Year Asset Revenue Profit
31 Mar 2023 374.06 Cr 262.70 Cr -2.11 Cr
31 Mar 2024 352.12 Cr 281.61 Cr 3.63 Cr
31 Mar 2025 381.76 Cr 276.09 Cr 10.50 Cr
DRHP DRAFT

About Amanta Healthcare Ltd. IPO

About Amanta Healthcare Limited 
Amanta Healthcare Limited is a pharmaceutical company focused on developing, manufacturing, and marketing a wide range of sterile liquid pr ...

Its portfolio includes both Large Volume Parenterals (LVPs) and Small Volume Parenterals (SVPs), along with medical devices. The therapeutic segments covered include fluid therapy (IV fluids), formulations, diluents, ophthalmic, respiratory care, and irrigation solutions.

In the medical devices category, the company produces irrigation solutions, first-aid solutions, and eye lubricants. The company provides multiple closure systems such as nipple head, twist-off, leur-lock, and screw types, with container sizes ranging from 2 ml to 1000 ml.

Supported by dedicated formulation and development (F&D) and quality control laboratories in Hariyala, District Kheda, Gujarat, the company works on both new formulations and improvements to existing ones. Its manufacturing facilities hold GMP certifications from global regulatory authorities, including WHO-recommended standards, and are approved for exports by several countries.

Amanta Healthcare markets products under its own brands in India through a strong network of 316 distributors and stockists, while also exporting to 19 countries across Africa, Latin America, the UK, and other regions. With a portfolio of 47 products registered in 112 international jurisdictions, the company operates through three key business units: national sales, international sales, and product partnering.

Its experienced management team and skilled workforce of professionals continue to support innovation, regulatory compliance, and growth in the pharmaceutical sector.

Read more
Amanta Healthcare Ltd. IPO Object of Issues

Amanta Healthcare IPO Objectives 
The company plans to allocate the net proceeds from the issuance to the following purposes:

  1. To fund capital expenditure for civil construction and purchase of equipment, plant, and machinery for setting up a new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat.
  2. To fund capital expenditure for civil construction and purchase of equipment, plant, and machinery for setting up a new manufacturing line for SVP at Hariyala, Kheda, Gujarat.
  3. The company plans to allocate funds towards overall business growth, strengthening operations, and supporting future opportunities.
Amanta Healthcare Ltd. IPO Company Promoters

Amanta Healthcare IPO Promoter Holding
The promoters of the Company are Bhavesh Patel, Vishal Patel, Jayshreeben Patel, Jitendra Kumar Patel and Milcent Appliances Private Limited.
Promoter Holding Pre Issue    85.60%
Promoter Holding Post Issue    63.56%
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue

FAQs

When Amanta Healthcare IPO will open?

The Amanta Healthcare IPO opens on September 1, 2025 and closes on September 3, 2025.

What is the lot size of Amanta Healthcare IPO?

Amanta Healthcare IPO lot size is 119, and the minimum amount required for application is ₹14,994.

When is Amanta Healthcare IPO listing date ?

The Amanta Healthcare IPO listing date is not yet announced. The tentative date of Amanta Healthcare IPO listing is Tuesday, September 9, 2025.

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, InvestExpert Academy does not take any liability for the genuineness and correctness of the information in this article.